Protia Inc. (KOSDAQ:303360)
South Korea · Delayed Price · Currency is KRW 4,635.00
-40.00 (-0.86%)
At close: Apr 9, 2026
Protia Market Cap
Protia has a market cap or net worth of 64.19 billion as of April 10, 2026. Its market cap has increased by 51.29% in one year.
Market Cap
64.19B
Enterprise Value
50.81B
Revenue
15.12B
Ranking
n/a
PE Ratio
14.37
Stock Price
4,635.00
Market Cap Chart
Since December 19, 2018, Protia's market cap has decreased from 78.41B to 64.19B, a decrease of -18.13%. That is a compound annual growth rate of -2.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 64.19B | -20.11% |
| Dec 30, 2025 | 80.35B | 127.74% |
| Dec 30, 2024 | 35.28B | -16.19% |
| Dec 28, 2023 | 42.10B | -45.57% |
| Dec 29, 2022 | 77.35B | 24.57% |
| Dec 30, 2021 | 62.09B | -38.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 494.11B |
| 3billion | 380.82B |
| GENINUS | 157.23B |
| HLB Panagene | 108.90B |
| Cytogen | 93.20B |
| Green Cross Medical Science | 79.79B |
| Seoulin Bioscience | 53.84B |
| GeneMatrix | 39.38B |